THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 70 filers reported holding THESEUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 959,275 | $5,305,000 | 13.37% |
| Foresite Capital Management V, LLC | 3,335,346 | $18,444,000 | 12.88% |
| Lynx1 Capital Management LP | 504,862 | $2,792,000 | 2.38% |
| Orbimed Advisors | 17,041,668 | $94,240,000 | 1.71% |
| Omega Fund Management, LLC | 711,479 | $3,934,000 | 1.26% |
| Nextech Invest Ltd. | 611,310 | $3,381,000 | 1.14% |
| Boxer Capital, LLC | 892,057 | $4,933,000 | 0.31% |
| DAFNA Capital Management LLC | 81,899 | $453,000 | 0.12% |
| Opaleye Management Inc. | 32,300 | $179,000 | 0.08% |
| Rock Springs Capital Management LP | 437,329 | $2,418,000 | 0.07% |